FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2911302692> ?p ?o ?g. }

• W2911302692 endingPage "231" @default.
• W2911302692 startingPage "225" @default.
• W2911302692 abstract "Aims Secondary angiosarcoma is known to be associated with lymphoedema or radiation after cancer treatment. This systematic review aims to evaluate the clinical features and outcomes of secondary angiosarcoma commonly arising after breast cancer treatment. Materials and methods A systematic review was carried out according to the PRISMA protocol. Medline, EMBASE, CINAHL and Cochrane databases were searched for English articles to April 2018 with predefined strategy. Retrieved studies were independently screened and rated for relevance. Data were extracted by two researchers. Results There were 72 secondary angiosarcomas of the limbs. Most patients (n = 68, 94.4%) had a history of lymphoedema. The median latent period was 15 years (range 3–40 years). Thirty-eight (52.8%) patients received wide excision or amputation as a treatment for the angiosarcoma, two (2.8%) patients received isolated limb perfusion and one (1.4%) patient received systemic chemotherapy. The remaining patients received palliative care/undocumented treatment. The pooled median duration to mortality was 10.5 months (range 1–144 months). Of note, obesity was documented in seven (9.7%) patients. There were 83 breast angiosarcomas; all with known breast cancer history. Thirty-one (37.3%) patients received mastectomy as breast cancer treatment. Fifty-four (65.1%) patients had a history of adjuvant radiotherapy for the primary breast cancer. The median latent period was 6 years (range 2–50 years); the median size was 40 mm (range 8–200 mm). Forty-one (49.4%) patients received wide excision, 19 (22.9%) patients received completion mastectomy and 23 (27.7%) patients have undocumented treatment for angiosarcoma. The pooled median duration to mortality was 31 months (range 6–168 months). Conclusion Angiosarcoma in lympedematous upper limbs or after breast cancer irradiation remains uncommon. However, its long latency and high mortality warrant long-term vigilant surveillance." @default.
• W2911302692 created "2019-02-21" @default.
• W2911302692 creator A5025137857 @default.
• W2911302692 creator A5069301453 @default.
• W2911302692 creator A5082253615 @default.
• W2911302692 date "2019-04-01" @default.
• W2911302692 modified "2023-10-01" @default.
• W2911302692 title "Cutaneous Angiosarcoma Secondary to Lymphoedema or Radiation Therapy — A Systematic Review" @default.
• W2911302692 cites W1500295622 @default.
• W2911302692 cites W1564703406 @default.
• W2911302692 cites W1581588088 @default.
• W2911302692 cites W1964241396 @default.
• W2911302692 cites W1966877620 @default.
• W2911302692 cites W1973148644 @default.
• W2911302692 cites W1981740888 @default.
• W2911302692 cites W1983045099 @default.
• W2911302692 cites W1992398878 @default.
• W2911302692 cites W1998630669 @default.
• W2911302692 cites W2005441474 @default.
• W2911302692 cites W2010093348 @default.
• W2911302692 cites W2010982978 @default.
• W2911302692 cites W2018696544 @default.
• W2911302692 cites W2021185349 @default.
• W2911302692 cites W2022625404 @default.
• W2911302692 cites W2029665350 @default.
• W2911302692 cites W2029893245 @default.
• W2911302692 cites W2045834200 @default.
• W2911302692 cites W2055655572 @default.
• W2911302692 cites W2059623721 @default.
• W2911302692 cites W2065037623 @default.
• W2911302692 cites W2072872060 @default.
• W2911302692 cites W2087745918 @default.
• W2911302692 cites W2089286484 @default.
• W2911302692 cites W2090806455 @default.
• W2911302692 cites W2106674368 @default.
• W2911302692 cites W2107993090 @default.
• W2911302692 cites W2109076534 @default.
• W2911302692 cites W2116810622 @default.
• W2911302692 cites W2117115672 @default.
• W2911302692 cites W2125713169 @default.
• W2911302692 cites W2131366550 @default.
• W2911302692 cites W2136482853 @default.
• W2911302692 cites W2142730057 @default.
• W2911302692 cites W2164797561 @default.
• W2911302692 cites W2235993933 @default.
• W2911302692 cites W2283971747 @default.
• W2911302692 cites W2320929039 @default.
• W2911302692 cites W2518565735 @default.
• W2911302692 cites W2525353062 @default.
• W2911302692 cites W2528580611 @default.
• W2911302692 cites W2618768366 @default.
• W2911302692 cites W2765907774 @default.
• W2911302692 cites W2904192497 @default.
• W2911302692 cites W4241497580 @default.
• W2911302692 cites W4246747306 @default.
• W2911302692 doi "https://doi.org/10.1016/j.clon.2019.01.009" @default.
• W2911302692 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30738715" @default.
• W2911302692 hasPublicationYear "2019" @default.
• W2911302692 type Work @default.
• W2911302692 sameAs 2911302692 @default.
• W2911302692 citedByCount "16" @default.
• W2911302692 countsByYear W29113026922019 @default.
• W2911302692 countsByYear W29113026922020 @default.
• W2911302692 countsByYear W29113026922021 @default.
• W2911302692 countsByYear W29113026922022 @default.
• W2911302692 countsByYear W29113026922023 @default.
• W2911302692 crossrefType "journal-article" @default.
• W2911302692 hasAuthorship W2911302692A5025137857 @default.
• W2911302692 hasAuthorship W2911302692A5069301453 @default.
• W2911302692 hasAuthorship W2911302692A5082253615 @default.
• W2911302692 hasConcept C121608353 @default.
• W2911302692 hasConcept C126322002 @default.
• W2911302692 hasConcept C141071460 @default.
• W2911302692 hasConcept C2777757722 @default.
• W2911302692 hasConcept C2779217266 @default.
• W2911302692 hasConcept C509974204 @default.
• W2911302692 hasConcept C530470458 @default.
• W2911302692 hasConcept C71924100 @default.
• W2911302692 hasConceptScore W2911302692C121608353 @default.
• W2911302692 hasConceptScore W2911302692C126322002 @default.
• W2911302692 hasConceptScore W2911302692C141071460 @default.
• W2911302692 hasConceptScore W2911302692C2777757722 @default.
• W2911302692 hasConceptScore W2911302692C2779217266 @default.
• W2911302692 hasConceptScore W2911302692C509974204 @default.
• W2911302692 hasConceptScore W2911302692C530470458 @default.
• W2911302692 hasConceptScore W2911302692C71924100 @default.
• W2911302692 hasIssue "4" @default.
• W2911302692 hasLocation W29113026921 @default.
• W2911302692 hasLocation W29113026922 @default.
• W2911302692 hasOpenAccess W2911302692 @default.
• W2911302692 hasPrimaryLocation W29113026921 @default.
• W2911302692 hasRelatedWork W1520527616 @default.
• W2911302692 hasRelatedWork W1989192296 @default.
• W2911302692 hasRelatedWork W2106765698 @default.
• W2911302692 hasRelatedWork W2250080440 @default.
• W2911302692 hasRelatedWork W2316817850 @default.
• W2911302692 hasRelatedWork W2376618735 @default.
• W2911302692 hasRelatedWork W2466949046 @default.

• next